DÃaz-Paredes, E.; MartÃn-Loro, F.; RodrÃguez-MarÃn, R.; Gómez-Jaramillo, L.; Sánchez-Fernández, E.M.; Carrillo-Carrión, C.; Arroba, A.I.
Exploring a Novel Anti-Inflammatory Therapy for Diabetic Retinopathy Based on Glyco-Zeolitic-Imidazolate Frameworks. Pharmaceutics 2025, 17, 791.
https://doi.org/10.3390/pharmaceutics17060791
AMA Style
DÃaz-Paredes E, MartÃn-Loro F, RodrÃguez-MarÃn R, Gómez-Jaramillo L, Sánchez-Fernández EM, Carrillo-Carrión C, Arroba AI.
Exploring a Novel Anti-Inflammatory Therapy for Diabetic Retinopathy Based on Glyco-Zeolitic-Imidazolate Frameworks. Pharmaceutics. 2025; 17(6):791.
https://doi.org/10.3390/pharmaceutics17060791
Chicago/Turabian Style
DÃaz-Paredes, Elena, Francisco MartÃn-Loro, RocÃo RodrÃguez-MarÃn, Laura Gómez-Jaramillo, Elena M. Sánchez-Fernández, Carolina Carrillo-Carrión, and Ana I. Arroba.
2025. "Exploring a Novel Anti-Inflammatory Therapy for Diabetic Retinopathy Based on Glyco-Zeolitic-Imidazolate Frameworks" Pharmaceutics 17, no. 6: 791.
https://doi.org/10.3390/pharmaceutics17060791
APA Style
DÃaz-Paredes, E., MartÃn-Loro, F., RodrÃguez-MarÃn, R., Gómez-Jaramillo, L., Sánchez-Fernández, E. M., Carrillo-Carrión, C., & Arroba, A. I.
(2025). Exploring a Novel Anti-Inflammatory Therapy for Diabetic Retinopathy Based on Glyco-Zeolitic-Imidazolate Frameworks. Pharmaceutics, 17(6), 791.
https://doi.org/10.3390/pharmaceutics17060791
